Riskpilot← Back to searchSign inGet full accessPROMEX HELSE AS
ASActiveOrg 881935082Stokmovegen 2, 7500 StjørdalRetail sale of pharmaceutical products · NACE 4773Est. 200010 employees
Revenue 2024
NOK 9,8M
-1% vs 2023
EBITDA margin
14.3%
+19% vs 2023
Equity ratio
77.2%
Financial strength
Net profit 2024
NOK 1,1M
+26% vs 2023
| Revenue | NOK 9,8M | -1% |
| EBITDA | NOK 1,4M | +19% |
| Net profit | NOK 1,1M | +26% |
| Total assets | NOK 9,6M | +5% |
| Equity | NOK 7,4M | +2% |
| Employees | 10 | — |
Legal name
PROMEX HELSE AS
Org number
881935082
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
3. mai 2000
Share capital
NOK 100 000
Employees
10 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Salg av sykepleieartikler, opplæring, konsulentvirksomhet og det som naturig følger med slik virksomhet, samt å delta i andre selskaper.
Address
Stokmovegen 2, 7500 Stjørdal
Phone
+4774801213
Email
post@promexhelse.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 927 | 9 099 | 9 545 | 9 873 | 9 813 |
| Staff expenses | −432 | −495 | −564 | −668 | −682 |
| EBITDA | 1 163 | 1 255 | 1 207 | 1 185 | 1 405 |
| Depreciation & amort. | −27 | −29 | −36 | −46 | −44 |
| EBIT | 1 136 | 1 226 | 1 171 | 1 139 | 1 361 |
| Net financials | −34 | −15 | 31 | −7 | 64 |
| Profit before tax | 1 102 | 1 212 | 1 202 | 1 132 | 1 425 |
| Tax | 242 | 258 | 247 | 240 | 302 |
| Net profit | 860 | 954 | 956 | 892 | 1 123 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7 739 | 8 192 | 8 716 | 9 116 | 9 571 |
| Equity | 6 263 | 6 717 | 7 172 | 7 265 | 7 388 |
| Long-term debt | 0 | 7 | 6 | 5 | 2 |
| Short-term debt | 1 476 | 1 468 | 1 538 | 1 847 | 2 182 |
| Total debt | 1 476 | 1 475 | 1 544 | 1 852 | 2 184 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20202024
Equity ratio
77.2%
This company
38.2%
Market median
+102% vs market
20202024
Return on equity
15.2%
This company
18.4%
Market median
+17% vs market
20202024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20202024
Asset turnover
1.03×
This company
1.12×
Market median
+8% vs market
20202024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
MK Chief Executive Officer | Chief Executive Officer | 2001 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2001 | |
| Chairman | 2001 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 60% | 60% | 2022 | |
| Company | 20% | 20% | 2022 | |
| Company | 20% | 20% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ltk Holding As
PROMEX HELSE AS Board members of PROMEX HELSE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Merete Klæth | Chief Executive Officer | 0 companies |
| Marte Cecilie Walker Klæth | Board of Directors | 0 companies |
| Lars Terje Klæth | Chairman | 0 companies |